Thyroid emergencies

Reviews in Endocrine and Metabolic Disorders

Volumn 4, Issue 2, 2003, Pages 129-136

  Sarlis, Nicholas J ^a,b   Gourgiotis, Loukas ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

Hypothyroidism; Levothyroxine; Liothyronine; Metabolic coma; Myxedema; Thyroid storm; Thyrotoxicosis

Indexed keywords

ATENOLOL; GLUCOCORTICOID; GUANETHIDINE; HYDROCORTISONE; IODINE; LIOTHYRONINE; LITHIUM CARBONATE; PROPRANOLOL; PROPYLTHIOURACIL; RESERPINE; THIAMAZOLE; THIONAMIDE; THYROXINE;

AGRANULOCYTOSIS; CENTRAL NERVOUS SYSTEM DEPRESSION; CLINICAL FEATURE; DRUG HYPERSENSITIVITY; HEART ARRHYTHMIA; HEART MUSCLE ISCHEMIA; HUMAN; HYPOTENSION; HYPOTHYROIDISM; MENTAL DISEASE; MYXEDEMA; REVIEW; SIDE EFFECT; THYROID CRISIS; TREATMENT INDICATION;

COMA; CRITICAL CARE; EMERGENCIES; HUMANS; MYXEDEMA; THYROID CRISIS; THYROID DISEASES; THYROID HORMONES;

EID: 0038374793     PISSN: 13899155     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1022933918182     Document Type: Review

References (67)

1. Wartofsky L. Thyrotoxic storm. In: Braverman LE, Utiger RD, eds. Werner's and Ingbar's The Thyroid: A Fundamental and Clinical Text. Philadelphia, PA: Lippincott Williams & Wilkins, 2000:679- 684.
2. Tietgens ST, Leinung MC. Thyroid storm. Med Clin North Am 1995;79:169-184.
3. Naito Y, Sone T, Kataoka K, Sawada M, Yamazaki K. Thyroid storm due to functioning metastatic thyroid carcinoma in a burn patient. Anesthesiology 1997;87:433-435.
4. Tewari K, Balderston KD, Carpenter SE, Major CA. Papillary thyroid carcinoma manifesting as thyroid storm of pregnancy: Case report. Am J Obstet Gynecol 1998;179:818-819.
5. Brooks MH, Waldstein SS. Free thyroxine concentrations in thyroid storm. Ann Intern Med 1980;93:694-697.
6. Jacobs HS, Mackie DB, Eastman CJ, Ellis SM, Ekins RP, McHardy-Young S. Total and free triiodothyronine and thyroxine levels in thyroid storm and recurrent hyperthyroidism. Lancet 1973;2:236-238.
7. McDermott MT, Kidd GS, Dodson LE, Jr. Hofeldt FD. Radioiodine-induced thyroid storm. Case report and literature review. Am J Med 1983;75:353-359.
8. Reed J, Bradley EL, IIIrd. Postoperative thyroid storm after lithium preparation. Surgery 1985;98:983-986.
9. Hershman JM. Free thyroxine in nonthyroidal illness; In: Chopra IJ, moderator: Thyroid function in nonthyroidal illness. Ann Intern Med 1983;98:946-957.
10. Chopra IJ, Solomon DH, Teco GN, Eisenberg JB. An inhibitor of the binding of thyroid hormones to serum proteins is present in extrathyroidal tissues. Science 1982;215:407-409.
11. Coulombe P, Dussault JH, Letarte J, Simmard SJ. Catecholamines metabolism in thyroid diseases. I. Epinephrine secretion rate in hyperthyroidism and hypothyroidism. J Clin Endocrinol Metab 1976;42:125-131.
12. Coulombe P, Dussault JH, Walker P. Catecholamine metabolism in thyroid disease. II. Norepinephrine secretion rate in hyperthyroidism and hypothyroidism. J Clin Endocrinol Metab 1977;44:1185-1189.
13. Coulombe P, Dussault JH, Walker P. Plasma catecholamine concentrations in hyperthyroidism and hypothyroidism. Metabolism 1976;25:973-979.
14. Bilezikian JP, Loeb JN, Gammon DE. The influence of hyperthyroidism and hypothyroidism on the beta-adrenergic responsiveness of the turkey erythrocyte. J Clin Invest 1979;63:184-192.
15. Silva JE. Catecholamines and the sympathoadrenal system in thyrotoxicosis. In: Braverman LE, Utiger RD, eds. Werner & Ingbar's The Thyroid A Fundamental and Clinical Text. Philadelphia, PA: Lippinkott Williams & Wilkins, 2000:642-651.
16. Burch HB, Wartofsky L. Life-threatening thyrotoxicosis. Thyroid storm. Endocrinol Metab Clin North Am 1993;22:263-277.
17. Blum M, Kranjac T, Park CM, Engleman RM. Thyroid storm after cardiac angiography with iodinated contrast medium. Occurrence in a patient with a previously euthyroid autonomous nodule of the thyroid. JAMA 1976;235:2324-2325.
18. Howton JC. Thyroid storm presenting as coma. Ann Emerg Med 1988;17:343-345.
19. Lahey FH. The crisis of exophthalmic goiter. N Engl J Med 1928;199:255-257.
20. Simon HB, Daniels GH. Hormonal hyperthermia: Endocrinologic causes of fever. Am J Med 1979;66:257-263.
21. Serri O, Gagnon RM, Goulet Y, Somma M. Coma secondary to apathetic thyrotoxicosis. Can Med Assoc J 1978;119:605-607.
22. Aiello DP, DuPlessis AJ, Pattishall EG, IIIrd, Kulin HE. Thyroid storm presenting with coma and seizures in a 3-year-old girl. Clin Pediatr (Phila) 1989;28:571-574.
23. Modignani RL, Venegoni M, Beretta F, Fassina S. Thyroid storm with encephalopathic symptoms due to Graves' disease and inappropriate secretion of thyrotropin. Ann Ital Med Int 1992;7:250-254.
24. Bhattacharyya A, Wiles PG. Thyrotoxic crisis presenting as acute abdomen. J R Soc Med 1997;90:681-682.
25. Cansler CL, Latham JA, Brown PM, Jr., Chapman WH. Magner JA. Duodenal obstruction in thyroid storm. South Med J 1997;90:1143- 1146.
26. Walter RM, Jr, Bartle WR. Rectal administration of propylthiouracil in the treatment of Graves' disease. Am J Med 1990;88:69-70.
27. Yeung SC, Go R, Balasubramanyam A. Rectal administration of iodide and propylthiouracil in the treatment of thyroid storm. Thyroid 1995;5:403-405.
28. Wu SY, Chopra IJ, Solomon DH, Johnson DE. The effect of repeated administration of ipodate (Oragrafin) in hyperthyroidism. J Clin Endocrinol Metab 1978;47:1358-1362.
29. Lazarus JH, Richards AR, Addison GM, Owen GM. Treatment of thyrotoxicosis with lithium carbonate. Lancet 1974;2:1160-1163.
30. Mazzaferri EL, Skillman TG. Thyroid storm. A review of 22 episodes with special emphasis on the use of guanethidine. Arch Intern Med 1969;124:684-690.
31. Anaissie E, Tohme JF. Reserpine in propranolol-resistant thyroid storm. Arch Intern Med 1985;145:2248-2249.
32. Feely J, Forrest A, Gunn A, Hamilton W, Stevenson I, Crooks J. Propranolol dosage in thyrotoxicosis. J Clin Endocrinol Metab 1980;51:658-661.
33. Rubenfeld S, Silverman VE, Welch KM, Mallette LE, Kohler PO. Variable plasma propranolol levels in thyrotoxicosis. N Engl J Med 1979;300:353-354.
34. Geffner DL, Hershman JM. Beta-adrenergic blockade for the treatment of hyperthyroidism. Am J Med 1992;93:61-68.
35. Brunette DD, Rothong C. Emergency department management of thyrotoxic crisis with esmolol. Am J Emerg Med 1991;9:232-234.
36. Isley WL, Dahl S, Gibbs H. Use of esmolol in managing a thyrotoxic patient needing emergency surgery. Am J Med 1990;89:122-123.
37. Ashkar FS, Katims RB, Smoak WM, IIIrd, Gilson AJ. Thyroid storm treatment with blood exchange and plasmapheresis. JAMA 1970;214:1275-1279.
38. Herrmann J, Hilger P, Kruskemper HL. Plasmapheresis in the treatment of thyrotoxic crisis (measurement of half-concentration times for free and total T3 and T4). Acta Endocrinol (Copenh) 1973;173(Suppl):22.
39. Burman KD, Yeager HC, Briggs WA, Earll JM, Wartofsky L. Resin hemoperfusion: A method of removing circulating thyroid hormones. J Clin Endocrinol Metab 1976;42:70-78.
40. Candrina R, Di Stefano O, Spandrio S, Giustina G. Treatment of thyrotoxic storm by charcoal plasmaperfusion. J Endocrinol Invest 1989;12:133-134.
41. Solomon BL, Wartofsky L, Burman KD. Adjunctive cholestyramine therapy for thyrotoxicosis. Clin Endocrinol (Oxf) 1993;38:39-43.
42. Larsen PR. Salicylate-induced increases in free triiodothyronine in human serum. Evidence of inhibition of triiodothyronine binding to thyroxine-binding globulin and thyroxine-binding prealbumin. J Clin Invest 1972;51:1125-1134.
43. Ureta-Raroque SS, Abramo TJ. Adolescent female patient with shock unresponsive to usual resuscitative therapy. Pediatr Emerg Care 1997;13:274-276.
44. Atwood JE, Albers GW. Anticoagulation and atrial fibrillation. Herz 1993;18:27-38 (In German).
45. Haynes JH, IIIrd, Kageler WV. Thyrocardiotoxic embolic syndrome. South Med J 1989;82:1292-1293.
46. Szilagyi DE, McGraw AB, Smyth NPD. The effects of adrenocortical stimulation on thyroid function: Clinical observations in thyrotoxic crisis and hyperthyroidism. Ann Surg 1952;136:555-577.
47. Wartofsky L. Myxedema coma. In: Braverman LE. Utiger RD, eds. Werner & Ingbar's The Thyroid A Fundamental and Clinical Text. Philadelphia, PA: Lippincott Williams & Wilkins, 2000:843-847.
48. Arlot S, Debussche X, Lalau JD, Mesmacque A, Tolani M, Quichaud J, Fournier A. Myxedema coma: Response of thyroid hormone with oral and intravenous high-dose L-thyroxine treatment. Intens Care Med 1991;17:16-18.
49. Zwillich CW, Pierson DJ, Hofeldt FD, Lufkin EG, Weil JV. Ventilatory control in myxedema and hypothyroidism. N Engl J Med 1975;292:662-665.
50. Wilson WR, Bedell GM. The pulmonary abnormalities in myxedema. J Clin Invest 1960;39:42-55.
51. Orr WC, Males JL, Imes NK. Myxedema and obstructive sleep apnea. Am J Med 1981;70:1061-1066.
52. Laroche CM, Cairns T, Moxham J, Green M. Hypothyroidism presenting with respiratory muscle weakness. Am Rev Respir Dis 1988;138:472-474.
53. Blum M. Myxedema coma. Am J Med Sci 1972;264:432-443.
54. Nicoloff JT, LoPresti JS, Myxedema coma: A form of decompensated hypothyroidism. Endocrinol Metab Clin North Am 1993;22:279-290.
55. Jordan RM. Myxedema coma: Pathophysiology, therapy, and factors affecting prognosis. Med Clin North Am 1995;1:185-194.
56. DeRubertis FR, Jr, Michelis MF, Bloom ME, Mintz DH, Field JB, Davis BB. Impaired water excretion in myxedema. Am J Med 1971;51:41-53.
57. Skowsky WR, Kikuchi TA. The role of vasopressin in the impaired water excretion of myxedema. Am J Med 1978;64:613-621.
58. Sanders V. Neurologic manifestations of myxedema. N Engl J Med 1962;266:547-551.
59. Hooper MJ. Diminished T.S.H. secretion during acute non-thyroidal illness in untreated primary hypothyroidism. Lancet 1976;1:48-49 (letter).
60. Wartofsky L, Burman KD. Alterations in thyroid function in patients with systemic illness: The "euthyroid sick syndrome". Endocr Rev 1982;3:164-217.
61. White GH, Walmsley RN. Plasma enzyme activities in primary hypothyroidism. Clin Chem 1984;30:323-327.
62. McKeran RO, Slavin G, Ward P, Paul E, Mair WG. Hypothyroid myopathy. A clinical and pathologaical study. J Pathol 1980;132:35-54.
63. Royce PC. Severely impaired consciousness in myxedema - A review. Am J Med Sci 1971;261:46-50.
64. Holvey DN, Goodner CJ, Nicoloff JT. Treatment of myxedema coma with intravenous thyroxine. Arch Intern Med 1964;113:89-96.
65. Ridgway EC, McCammon JA, Benotti J, Maloof F. Acute metabolic responses in myxedema to large doses of intravenous L-thyroxine. Ann Intern Med 1972;77:549-555.
66. Chernow B, Burman KD, Johnson DL, McGuire RA, O'Brian JT, Wartofsky L, Georges LP. T3 may be a better agent than T4 in the critically ill hypothyroid patient: Evaluation of transport across the blood-brain barrier in a primate model. Crit Care Med 1983;11:99-104.
67. Hylander B, Rosenqvist U. Treatment of myxoedema coma Factors associated with fatal outcome. Acta Endocrinol (Copenh) 1985;108:65-71.